[PDF] academia.edu

[PDF][PDF] Anticancer drugs as potential inhibitors of AcrAB-TolC of multidrug resistant Escherichia coli: an in silico molecular modeling and docking study

P GUPTA, N RAI, P GAUTAM - Anticancer Drugs, 2015 - academia.edu
ABSTRACT Objective: Overexpression of AcrAB-TolC protein complex is often associated
with the virulence of multidrug-resistant bacteria. Development of an effective efflux pump …
被引用次数：8 相关文章
[PDF] academia.edu

[PDF][PDF] ANTICANCER DRUGS AS POTENTIAL INHIBITORS OF ACRAB-TOLC OF MULTIDRUG RESISTANT ESCHERICHIA COLI: AN IN SILICO MOLECULAR …

P GUPTA, N RAI, P GAUTAM - ANTICANCER DRUGS, 2015 - academia.edu
ABSTRACT Objective: Overexpression of AcrAB-TolC protein complex is often associated
with the virulence of multidrug-resistant bacteria. Development of an effective efflux pump …
[PDF] researchgate.net

[PDF][PDF] ANTICANCER DRUGS AS POTENTIAL INHIBITORS OF ACRAB-TOLC OF MULTIDRUG RESISTANT ESCHERICHIA COLI: AN IN SILICO MOLECULAR …

P GUPTA, N RAI, P GAUTAM - ANTICANCER DRUGS, 2015 - researchgate.net
ABSTRACT Objective: Overexpression of AcrAB-TolC protein complex is often associated
with the virulence of multidrug-resistant bacteria. Development of an effective efflux pump …
[PDF] psu.edu

[PDF][PDF] ANTICANCER DRUGS AS POTENTIAL INHIBITORS OF ACRAB-TOLC OF MULTIDRUG RESISTANT ESCHERICHIA COLI: AN IN SILICO MOLECULAR …

P GUPTA, N RAI, P GAUTAM - ANTICANCER DRUGS, 2015 - Citeseer
ABSTRACT Objective: Overexpression of AcrAB-TolC protein complex is often associated
with the virulence of multidrug-resistant bacteria. Development of an effective efflux pump …